Drug Details
General Information of the Drug (ID: DR9368) | ||||
---|---|---|---|---|
Name |
Folfox
|
|||
Synonyms |
Folfox protocol; Folfox regimen; FOLFOX-4 protocol; FOLFOX-6 protocol; FOLFOX-7 protocol; Folfox; FOLFOX-4; FOLFOX-6; FOLFOX-7; C410216000; Fluorouracil regimen with leucovorin calcium and oxaliplatin
Click to Show/Hide
|
|||
Molecular Type |
Small molecule
|
|||
Disease | Colorectal cancer [ICD-11: 2B91] | Approved | [1] | |
Structure |
Click to Download Mol2D MOL |
|||
Click to Show/Hide the Molecular Information and External Link(s) of This Natural Product | ||||
Formula |
C34H42FN9O13Pt
|
|||
PubChem CID | ||||
Canonical SMILES |
[CH2-]C1CCCCC1[CH2-].C1C(N(C2=C(N1)N=C(NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O.C1=C(C(=O)NC(=O)N1)F.C(=O)(C(=O)O)O.[Pt+2]
|
|||
InChI |
1S/C20H23N7O7.C8H14.C4H3FN2O2.C2H2O4.Pt/c21-20-25-16-15(18(32)26-20)27(9-28)12(8-23-16)7-22-11-3-1-10(2-4-11)17(31)24-13(19(33)34)5-6-14(29)30;1-7-5-3-4-6-8(7)2;5-2-1-6-4(9)7-3(2)8;3-1(4)2(5)6;/h1-4,9,12-13,22H,5-8H2,(H,24,31)(H,29,30)(H,33,34)(H4,21,23,25,26,32);7-8H,1-6H2;1H,(H2,6,7,8,9);(H,3,4)(H,5,6);/q;-2;;;+2/t12?,13-;7-,8-;;;/m01.../s1
|
|||
InChIKey |
YXTKHLHCVFUPPT-YYFJYKOTSA-N
|
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
---|---|---|---|---|---|---|
α. A List of Natural Product(s) Able to Decrease the Adverse Effect of This Drug | ||||||
Glycine | Musa x paradisiaca | Click to Show/Hide the Molecular Data of This NP | ||||
Decreasing Adverse Drug Reaction | Click to Show/Hide | |||||
Representative Experiment Reporting the Effect of This Combination | [2] | |||||
Detail(s) | Combination Info click to show the detail info of this combination | |||||
Molecule(s)
Regulation |
Up-regulation | Expression | FABP3 | Molecule Info |
Pathway MAP
|
|
In-vitro Model | Human cardiac myocytes | Healthy | Homo sapiens | |||
In-vivo Model | For a xenograft model, CC531 cells were injected into the right liver lobe of seven-week-old male Wag/Rij rats. | |||||
Experimental
Result(s) |
Dietary glycine protects the heart against FOLFOX-induced injury during treatment for CRLM. |
Target and Pathway | ||||
---|---|---|---|---|
Target(s) | Carbonic anhydrase (CA) | Molecule Info | [3] |